Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction
Atul Verma, Jonathan M. Kalman, David J. Callans
Circulation (2017) Vol. 135, Iss. 16, pp. 1547-1563
Open Access | Times Cited: 108

Showing 26-50 of 108 citing articles:

Safety of catheter ablation for atrial fibrillation in the octogenarian population
Jorge Romero, Gbolahan Ogunbayo, Samy Claude Elayi, et al.
Journal of Cardiovascular Electrophysiology (2019) Vol. 30, Iss. 12, pp. 2686-2693
Closed Access | Times Cited: 25
Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis
Ting Gan, Jing Hu, Anwer Khalid Okab Aledan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials
Chun Lin, Mingyan Sun, Youbin Liu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Effects of Phenylacetylglutamine on the Susceptibility of Atrial Fibrillation in Overpressure-Induced HF Mice
Hui Fu, Dengke Li, Wei Shuai, et al.
Molecular and Cellular Biology (2024) Vol. 44, Iss. 4, pp. 149-163
Open Access | Times Cited: 2
Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure
Lan Gao, Marj Moodie
BMJ Open (2019) Vol. 9, Iss. 9, pp. e031033-e031033
Open Access | Times Cited: 20
The management of atrial fibrillation in heart failure: an expert panel consensus
Dimitrios Farmakis, Christina Chrysohoou, Grigorios Giamouzis, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 6, pp. 1345-1358
Closed Access | Times Cited: 19
Tricuspid Regurgitation in Left Ventricular Systolic Dysfunction: Marker or Target?
Davide Margonato, Francesco Ancona, Giacomo Ingallina, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 16
DNA Methylation-Based Prediction of Post-operative Atrial Fibrillation
Matthew A. Fischer, Aman Mahajan, Maximilian Cabaj, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review
Xiaolan Ouyang, Jiafu Wang, Qian Chen, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia
Anders Hovland, Liv Mundal, Jannicke Igland, et al.
Atherosclerosis (2017) Vol. 266, pp. 69-73
Closed Access | Times Cited: 19
Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction
Jackson J. Liang, David J. Callans
Cardiac failure review (2018) Vol. 4, Iss. 1, pp. 1-1
Open Access | Times Cited: 19
Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: study protocol
Luis Sánchez-Trujillo, Carlos Jerjes‐Sánchez, David Rodríguez, et al.
BMJ Open (2019) Vol. 9, Iss. 3, pp. e022826-e022826
Open Access | Times Cited: 18
Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register
И. В. Жиров, Natalia V. Safronova, Yu. F. Osmolovskaya, et al.
Russian Journal of Cardiology (2021) Vol. 26, Iss. 1, pp. 4200-4200
Open Access | Times Cited: 14
Hyponatremia in patients with atrial fibrillation and heart failure: The difficult triangle
Evangelos Oikonomou, Vasiliki-Chara Mystakidi, Dimitris Tousoulis
Hellenic Journal of Cardiology (2019) Vol. 60, Iss. 2, pp. 122-123
Open Access | Times Cited: 14
Sodium-glucose cotransporter-2 inhibitors protect against atrial fibrillation in patients with heart failure
Lili Zhou, Yuanyuan Yang, Weixing Han
Annals of Palliative Medicine (2021) Vol. 10, Iss. 10, pp. 10887-10895
Open Access | Times Cited: 12
Atrial Fibrillation Ablation in Patients with Heart Failure: One Size Does Not Fit All
Rahul Mukherjee, Steven E. Williams, Steven Niederer, et al.
Arrhythmia & Electrophysiology Review (2018) Vol. 7, Iss. 2, pp. 84-84
Open Access | Times Cited: 13
Implantable Cardioverter–Defibrillators in Trials of Drug Therapy for Heart Failure: A Systematic Review and Meta‐Analysis
F Gama, Jorge Ferreira, J. P. Carmo, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 8
Open Access | Times Cited: 12
Pathophysiological pathways in patients with heart failure and atrial fibrillation
Bernadet T. Santema, Vicente Artola Arita, Iziah E Sama, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 11, pp. 2478-2487
Open Access | Times Cited: 11
Research Progress of Triglyceride Glucose Index in Patients with Heart Failure and Atrial Fibrillation
家瑶 路
Advances in Clinical Medicine (2024) Vol. 14, Iss. 01, pp. 1841-1846
Closed Access | Times Cited: 1
Catheter ablation for atrial fibrillation: current patient selection and outcomes
Katie Walsh, Francis E. Marchlinski
Expert Review of Cardiovascular Therapy (2018) Vol. 16, Iss. 9, pp. 679-692
Closed Access | Times Cited: 12
Electrochemically driven optical and SERS immunosensor for the detection of a therapeutic cardiac drug
Madeeha Chaudhry, Dong‐Kwon Lim, Jeon Woong Kang, et al.
RSC Advances (2022) Vol. 12, Iss. 5, pp. 2901-2913
Open Access | Times Cited: 7
A comparison of medical therapy and ablation for atrial fibrillation in patients with heart failure
Peter Calvert, J Farinha, Dhiraj Gupta, et al.
Expert Review of Cardiovascular Therapy (2022) Vol. 20, Iss. 3, pp. 169-183
Closed Access | Times Cited: 7
Clinical outcomes and structural remodelling after ablation of atrial fibrillation in heart failure with mildly reduced or mid‐range ejection fraction
Dan‐Ying Lee, Ting‐Yung Chang, Shih‐Lin Chang, et al.
ESC Heart Failure (2022) Vol. 10, Iss. 1, pp. 177-188
Open Access | Times Cited: 7
Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart Failure Status
Alessandro Capucci, Jorge Wong, Michael R. Gold, et al.
JACC. Clinical electrophysiology (2021) Vol. 8, Iss. 2, pp. 182-193
Open Access | Times Cited: 8
Catheter Ablation for Atrial Fibrillation in Systolic Heart Failure Patients: Stone by Stone, a CASTLE
Dimitrios A. Vrachatis, Spyridon Deftereos, Vasileios Kekeris, et al.
Arrhythmia & Electrophysiology Review (2018) Vol. 7, Iss. 4, pp. 1-1
Open Access | Times Cited: 7

Scroll to top